Education
About Us
Working with TipRanks
Follow Us
Champions Oncology (CSBR)
:CSBR
Total Valuation
Champions Oncology has a market cap or net worth of $109.23M. The enterprise value is $161.36M.
Market Cap$109.23M
Enterprise Value$161.36M
Share Statistics
Champions Oncology has 13,826,904 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding13,826,904
Owned by Insiders14.20%
Owned by Institutions34.48%
Financial Efficiency
Champions Oncology’s return on equity (ROE) is 3.82 and return on invested capital (ROIC) is -100.81%.
Return on Equity (ROE)3.82
Return on Assets (ROA)-0.28
Return on Invested Capital (ROIC)-100.81%
Return on Capital Employed (ROCE)-1.60
Revenue Per Employee238.83K
Profits Per Employee-34.65K
Employee Count210
Asset Turnover1.92
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Champions Oncology is -9.03. Champions Oncology’s PEG ratio is -0.23.
PE Ratio-9.03
PS Ratio2.26
PB Ratio-34.53
Price to Fair Value-34.53
Price to FCF-9.42
Price to Operating Cash Flow-10.71
PEG Ratio-0.23
Income Statement
In the last 12 months, Champions Oncology had revenue of 50.16M and earned -7.28M in profits. Earnings per share was -0.54.
Revenue50.16M
Gross Profit20.75M
Operating Income-7.36M
Pretax Income-7.31M
Net Income-7.28M
EBITDA-5.05M
Earnings Per Share (EPS)-0.54
Cash Flow
In the last 12 months, operating cash flow was -1.30M and capital expenditures -25.00K, giving a free cash flow of -1.32M billion.
Operating Cash Flow-1.30M
Free Cash Flow-1.32M
Free Cash Flow per Share-0.10
Dividends & Yields
Champions Oncology pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.75
52-Week Price Change60.57%
50-Day Moving Average9.22
200-Day Moving Average6.72
Relative Strength Index (RSI)43.83
Average Volume (3m)37.28K
Important Dates
Champions Oncology upcoming earnings date is Jul 17, 2025, TBA Not Confirmed.
Last Earnings DateMar 11, 2025
Next Earnings DateJul 17, 2025
Ex-Dividend Date―
Financial Position
Champions Oncology as a current ratio of 0.63, with Debt / Equity ratio of 117.70%
Current Ratio0.63
Quick Ratio0.63
Debt to Market Cap0.02
Net Debt to EBITDA-0.95
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Champions Oncology has paid -32.00K in taxes.
Income Tax-32.00K
Effective Tax Rate<0.01
Enterprise Valuation
Champions Oncology EV to EBITDA ratio is -13.95, with an EV/FCF ratio of -10.11.
EV to Sales1.41
EV to EBITDA-13.95
EV to Free Cash Flow-10.11
EV to Operating Cash Flow-11.49
Balance Sheet
Champions Oncology has $3.20M in cash and marketable securities with $6.44M in debt, giving a net cash position of $3.23M billion.
Cash & Marketable Securities$3.20M
Total Debt$6.44M
Net Cash$3.23M
Net Cash Per Share$0.23
Tangible Book Value Per Share-$0.17
Margins
Gross margin is 52.19%, with operating margin of -14.67%, and net profit margin of -14.51%.
Gross Margin52.19%
Operating Margin-14.67%
Pretax Margin-14.57%
Net Profit Margin-14.51%
EBITDA Margin-10.08%
EBIT Margin-13.80%
Analyst Forecast
The average price target for Champions Oncology is $12.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$12.00
Price Target Upside51.90% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast19.03%
EPS Growth Forecast―